Cachexia is a devastating, multifactorial and often irreversible systemic syndrome
characterized by substantial weight loss (mainly of skeletal muscle and adipose tissue) that …

Cancer cachexia is a complex multifaceted syndrome involving functional impairment and
changes in body composition that cannot be reversed by nutritional support. Cancer …

Each year, new drugs are introduced to the market, representing structures that have affinity
for biological targets implicated in human diseases and conditions. These new chemical …

Cancer cachexia, or the unintentional loss of body weight in patients with cancer, is a
multiorgan and multifactorial syndrome with a complex and largely unknown etiology; …

Background The prevalence of breast cancer and its mortality rate are increasing rapidly
among women worldwide. On other hand, the courses of chemotherapy as the main …

Cancer cachexia is defined as unintentional weight loss secondary to neoplasia and is
associated with poor prognosis and outcomes. Cancer cachexia associated weight loss …

Cancer cachexia (CC) is a multifactorial and complex syndrome experienced by up to 80%
of patients with cancer and implicated in∼ 40% of cancer-related deaths. Given its …

Simple Summary This study compared mirtazapine with megestrol in the management of
cancer-related anorexia–cachexia syndrome in patients with advanced cancer. This is a …

Cancer-associated cachexia occurs in 50% to 80% of cancer patients and is responsible for
20% to 30% of cancer-related deaths. Cachexia limits survival and treatment outcomes, and …

An evaluation of the behavioral risk factors that contribute to the incidence and evolution of
cancer in oncology patients was conducted through a cross-sectional study using a …